These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections. Cross SA; Scott LJ Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009 [TBL] [Abstract][Full Text] [Related]
3. Antifungal therapies in murine infections by Candida kefyr. Sanchis M; Martin-Vicente A; Capilla J; Guarro J Mycoses; 2016 Apr; 59(4):253-258. PubMed ID: 26857550 [TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species. Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease. Cornely OA; Marty FM; Stucker F; Pappas PG; Ullmann AJ Mycoses; 2011 Nov; 54(6):e838-47. PubMed ID: 21668522 [TBL] [Abstract][Full Text] [Related]
6. [Guidelines for the management of deep mycosis in neutropenic patients]. Yoshida M Nihon Ishinkin Gakkai Zasshi; 2004; 45(4):209-15. PubMed ID: 15550917 [TBL] [Abstract][Full Text] [Related]
7. Micafungin plus fluconazole in an infected knee with retained hardware due to Candida albicans. Bland CM; Thomas S Ann Pharmacother; 2009 Mar; 43(3):528-31. PubMed ID: 19261955 [TBL] [Abstract][Full Text] [Related]
8. The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Matsumoto Y; Murat D; Kojima T; Shimazaki J; Tsubota K Br J Ophthalmol; 2011 Oct; 95(10):1406-9. PubMed ID: 21097785 [TBL] [Abstract][Full Text] [Related]
9. [Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B]. Saitoh T; Matsushima T; Shimizu H; Osaki Y; Yamane A; Irisawa H; Yokohama A; Uchiumi H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H Rinsho Ketsueki; 2008 Feb; 49(2):94-8. PubMed ID: 18341039 [TBL] [Abstract][Full Text] [Related]
10. Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits. Petraitiene R; Petraitis V; Hope WW; Walsh TJ Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S643-51. PubMed ID: 26567283 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis. Petraitiene R; Petraitis V; Hope WW; Mickiene D; Kelaher AM; Murray HA; Mya-San C; Hughes JE; Cotton MP; Bacher J; Walsh TJ Antimicrob Agents Chemother; 2008 Nov; 52(11):4121-9. PubMed ID: 18779361 [TBL] [Abstract][Full Text] [Related]
12. [Current candidiasis topics: monitoring Liposomal amphotericin B using candidiasis flow charts (discussion)]. Takesue Y Jpn J Antibiot; 2012 Apr; 65(2):111-9. PubMed ID: 22970634 [No Abstract] [Full Text] [Related]
13. Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis. Takazono T; Izumikawa K; Mihara T; Kosai K; Saijo T; Imamura Y; Miyazaki T; Seki M; Kakeya H; Yamamoto Y; Yanagihara K; Kohno S Antimicrob Agents Chemother; 2009 Aug; 53(8):3508-10. PubMed ID: 19528281 [TBL] [Abstract][Full Text] [Related]
14. [Clinical use of micafungin for the treatment of invasive candidiasis in critical ill patients]. Pozo-Laderas JC Rev Iberoam Micol; 2009 Mar; 26(1):69-74. PubMed ID: 19463281 [TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Park BJ; Park JC; Taguchi H; Fukushima K; Hyon SH; Takatori K Biochem Biophys Res Commun; 2006 Aug; 347(2):401-5. PubMed ID: 16831406 [TBL] [Abstract][Full Text] [Related]
16. Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution. Liew YX; Teo J; Too IA; Ngan CC; Tan AL; Chlebicki MP; Kwa AL; Lee W BMC Infect Dis; 2015 Jul; 15():256. PubMed ID: 26137997 [TBL] [Abstract][Full Text] [Related]
17. Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany. Cornely OA; Sidhu M; Odeyemi I; van Engen AK; van der Waal JM; Schoeman O Curr Med Res Opin; 2008 Jun; 24(6):1743-53. PubMed ID: 18477422 [TBL] [Abstract][Full Text] [Related]
18. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)]. Ikeda F Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia. Chandrasekar P; Sirohi B; Seibel NL; Hsu JW; Azie N; Wu C; Ruhnke M Mycoses; 2018 May; 61(5):331-336. PubMed ID: 29364548 [TBL] [Abstract][Full Text] [Related]
20. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A; Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]